Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016 (2016), Article ID 2358321, 5 pages
http://dx.doi.org/10.1155/2016/2358321
Research Article

Fibrinogen: A Marker in Predicting Diabetic Foot Ulcer Severity

1Health Management Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
2Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
3Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China

Received 12 August 2016; Accepted 10 November 2016

Academic Editor: Andrea Flex

Copyright © 2016 X. H. Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Margolis and W. Jeffcoate, “Epidemiology of foot ulceration and amputation: can global variation be explained?” Medical Clinics of North America, vol. 97, no. 5, pp. 791–805, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Martins-Mendes, M. Monteiro-Soares, E. J. Boyko et al., “The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk,” Journal of Diabetes and Its Complications, vol. 28, no. 5, pp. 632–638, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Michail, E. Jude, C. Liaskos et al., “The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis,” International Journal of Lower Extremity Wounds, vol. 12, no. 2, pp. 94–99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Singh, D. G. Armstrong, and B. A. Lipsky, “Preventing foot ulcers in patients with diabetes,” The Journal of the American Medical Association, vol. 293, no. 2, pp. 217–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. G. Mesa, H. Á. Duarte, J. H. Carretero, M. M. Fors López, and M. M. Vilas, “De Marco Formula effectiveness as an adjunctive therapy to prevent infected ischemic diabetic foot amputation and reduce plasma fibrinogen,” Journal of Tissue Viability, vol. 20, no. 2, pp. 67–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Demetriou, N. Papanas, M. Panopoulou, K. Papatheodorou, and E. Maltezos, “Determinants of microbial load in infected diabetic foot ulcers: a pilot study,” International Journal of Endocrinology, vol. 2013, Article ID 858206, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Tabur, M. A. Eren, Y. Çelik et al., “The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration,” Wiener Klinische Wochenschrift, vol. 127, no. 1-2, pp. 45–50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Weigelt, B. Rose, U. Poschen et al., “Immune mediators in patients with acute diabetic foot syndrome,” Diabetes Care, vol. 32, no. 8, pp. 1491–1496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Rattan and D. Nayak, “High levels of plasma malondialdehyde, protein carbonyl, and fibrinogen have prognostic potential to predict poor outcomes in patients with diabetic foot wounds: a preliminary communication,” International Journal of Lower Extremity Wounds, vol. 7, no. 4, pp. 198–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Li, T. Xiao, Y. Wang et al., “Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital,” Diabetes Research and Clinical Practice, vol. 93, no. 1, pp. 26–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. A. Pearson, G. A. Mensah, R. W. Alexander et al., “Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association,” Circulation, vol. 107, no. 3, pp. 499–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. L. A. Lavery, D. G. Armstrong, R. P. Wunderlich, J. Tredwell, and A. J. M. Boulton, “Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort,” Diabetes Care, vol. 26, no. 5, pp. 1435–1438, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Tuttolomondo, C. Maida, and A. Pinto, “Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients,” Journal of Diabetes Research, vol. 2015, Article ID 268390, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. K. L. Wong, A. Nather, S. Liang, Z. Chang, T. T. C. Wong, and C. T. Lim, “Clinical outcomes of below knee amputations in diabetic foot patients,” Annals of the Academy of Medicine Singapore, vol. 42, no. 8, pp. 388–394, 2013. View at Google Scholar · View at Scopus
  15. C.-W. Lin, L.-A. Hsu, C.-C. Chen et al., “C-reactive protein as an outcome predictor for percutaneous transluminal angioplasty in diabetic patients with peripheral arterial disease and infected foot ulcers,” Diabetes Research and Clinical Practice, vol. 90, no. 2, pp. 167–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. B. Smith, “Fibrinogen, fibrin and the arterial wall,” European Heart Journal, vol. 16, pp. 11–15, 1995. View at Google Scholar · View at Scopus
  17. G. D. O. Lowe, “Fibrinogen and cardiovascular disease: historical introduction,” European Heart Journal, vol. 16, pp. 2–5, 1995. View at Google Scholar · View at Scopus
  18. J. Danesh, S. Lewington, S. G. Thompson et al., “Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis,” JAMA, vol. 294, no. 14, pp. 1799–1809, 2005. View at Google Scholar
  19. S. K. Kunutsor, S. Kurl, F. Zaccardi, and J. A. Laukkanen, “Baseline and long-term fibrinogen levels and risk of sudden cardiac death: a new prospective study and meta-analysis,” Atherosclerosis, vol. 245, pp. 171–180, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. S. G. Thompson, J. Kienast, S. D. Pyke, F. Haverkate, and J. C. van de Loo, “Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group,” The New England Journal of Medicine, vol. 332, no. 10, pp. 635–641, 1995. View at Google Scholar
  21. S. C. Howard, A. Algra, and P. M. Rothwell, “Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke,” Cerebrovascular Diseases, vol. 25, no. 1-2, pp. 136–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Y. H. Lip and G. D. O. Lowe, “Fibrin D-dimer: a useful clinical marker of thrombogenesis?” Clinical Science, vol. 89, no. 3, pp. 205–214, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. J. W. Yarnell, I. A. Baker, P. M. Sweetnam et al., “Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease—the caerphilly and speedwell collaborative heart disease studies,” Circulation, vol. 83, no. 3, pp. 836–844, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Thaulow, J. Erikssen, L. Sandvik, H. Stormorken, and P. F. Cohn, “Blood platelet count and function are related to total and cardiovascular death in apparently healthy men,” Circulation, vol. 84, no. 2, pp. 613–617, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Papageorgiou, D. Tousoulis, G. Siasos, and C. Stefanadis, “Is fibrinogen a marker of inflammation in coronary artery disease?” Hellenic Journal of Cardiology, vol. 51, no. 1, pp. 1–9, 2010. View at Google Scholar · View at Scopus
  26. S. Kotbi, A. Mjabber, A. Chadli et al., “Correlation between the plasma fibrinogen concentration and coronary heart disease severity in Moroccan patients with type 2 diabetes. Prospective study,” Annales d'Endocrinologie, vol. 77, no. 5, pp. 606–614, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Q. Yao, F. J. Wang, and Z. Kang, “Effects of endovascular interventions on vWF and Fb levels in type 2 diabetic patients with peripheral artery disease,” Annals of Vascular Surgery, vol. 33, pp. 159–166, 2016. View at Publisher · View at Google Scholar